April 2, 2003
Tyco Healthcare Has Recalled MD-Gastroview
The Food and Drug
Administration (FDA) has released the following information.
MD-Gastroview, (Diatrizoate Meglumine 660mg and Diatrizoate Sodium 100mg,
Injection, USP), 120mL amber glass, screw cap bottles, 367mg/mL Organically
Bound Iodine, Rx only. For Gastrointestinal radiography, Not For Parenteral
Use. Recall # D-179-3.
Lot numbers E009A and E026A.
Tyco Healthcare, Raleigh, NC, by letter on February 24, 2003. Firm initiated
recall is ongoing.
Misbranded; incorrectly labeled Diatrizoate Meglumine, Diatrizoate Sodium
Injection rather than Diatrizoate Meglumine, Diatrizoate Sodium Solution.
VOLUME OF PRODUCT IN COMMERCE
3138 cases of lot E009A;
3134 cases of lot E026A.
Nationwide, Argentina and Costa Rica.